Among other possible biomarkers, D-dimer is often elevated in COVID-19 patients (4, 5) and should be regarded as the most important parameter for stratification in terms of thromboembolic risk; it should be used together with other inflammatory markers, such as C-reactive protein, interleukin 6 (IL-6), and ferritin. The gene discussed is CRP; the disease is COVID-19.